PRNP and Creutzfeldt Jacob disease: 2-OPRI is different from highly penetrant mutations of PRNP, which make CJD inevitable or highly likely in a lifetime; rather, the 2-OPRI mutation increases the risk of CJD, but only to the extent that the lifetime risk for carriers is approximately 1 in 500.